BDNF and juvenile Huntington disease: The underlying molecular mechanism of glatiramer acetate in enhancing the expression of Bdnf mRNA is related to the induction of promoter I‐ and IV‐driven Bdnf expression and reduced levels of cytokines, in particular, interleukins IL4 and IL12, in the brains of Huntington disease mice [106].